El cáncer de pulmón representa una de las principales causas de mortalidad por cáncer a nivel mundial. Cada año se diagnostican 2.2 millones de nuevos casos, cuyo pronóstico depende de cómo de t...
Read moreBiorce, a Barcelona based TechBio company dedicated to transforming clinical trials through artificial intelligence, has announced the successful completion of a €3.5 million funding round. The inve...
Read moreLeishGenApp and LeishGenR are Nano1Health’s cutting-edge solutions for detecting drug resistance biomarkers in Leishmania infantum, tailored to meet the needs of researchers, veterinarians, and phys...
Read moreLa tesis de la Dra. Salma Hbachi, presentada en IQS, ofrece orientación sobre el desarrollo de futuras tecnologías y profundiza en la comprensión de la interacción humano-digital en el contexto de...
Read moreThe Drug Screening Platform at IRB Barcelona was launched 3 years ago to support the scientific community in the early stages of drug development.
Read moreINCE es la primera aplicación con evidencia científica a nivel internacional que permite medir la severidad de síntomas gastrointestinales, dolor y reactividad sensorial
Read moreLet’s look at the most noteworthy news from November, showcasing the vibrancy and constant innovation in the BioRegion of Catalonia, from basic research to clinical applications and international bu...
Read moreIt is a software that will allow insulin doses to be adjusted more appropriately to the blood glucose levels of patients with diabetes who are admitted to both hospitals and other healthcare centers
Read moreResearchers from Hospital Clínic-IDIBAPS have coordinated a study comparing the efficacy of artificial intelligence-assisted colonoscopy versus high-definition white-light colonoscopy in the detectio...
Read moreThe research, published in the scientific journal European Journal of Human Genetics, has been enabled by SolveRD, a project funded by the European Commission, in which Hospital Sant Joan de Déu a...
Read moreLa mortalidad en la Unidad de Ictus ha disminuido un 10% y la estancia hospitalaria se ha reducido un día en los últimos doce meses
Read moreInvestigadores de la Universidad de Stanford y el Instituto Arc han desarrollado Evo, una inteligencia artificial capaz de generar secuencias genómicas sintéticas desde cero. La herramienta, entrena...
Read more